Active site mutant acetylcholinesterase interactions with 2-PAM, HI-6, and DDVP

Biochemical and Biophysical Research Communications

Volumn 342, Issue 3, 2006, Pages 973-978

  Kovarik, Zrinka ^a   Ciban, Nikolina ^a   Radić, Zoran ^b   Simeon Rudolf, Vera ^a   Taylor, Palmer ^b  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

2 PAM; Acetylcholinesterase; Antidotes; Butyrylcholinesterase; HI 6; Phosphorylation; Reactivation; Reversible inhibition

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; CHOLINESTERASE; DICHLORVOS; ORGANOPHOSPHORUS COMPOUND; OXIME; PRALIDOXIME; RECOMBINANT ENZYME;

ARTICLE; BINDING AFFINITY; ENZYME INHIBITION; GENE MUTATION; PHOSPHORYLATION; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ANIMALS; BINDING SITES; DICHLORVOS; DRUG INTERACTIONS; MICE; MUTATION; PRALIDOXIME COMPOUNDS; PYRIDINIUM COMPOUNDS; RECOMBINANT PROTEINS;

EID: 33644621136     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.056     Document Type: Article

References (24)

1. M. Cygler, J.D. Schrag, J.L. Sussman, M. Harel, I. Silman, M.K. Gentry, and B.P. Doctor Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related enzymes Prot. Sci. 2 1993 366 382
2. Z. Radić, N.A. Pickering, D.C. Vellom, S. Camp, and P. Taylor Three distinct domains in the cholinesterase molecule confer selectivity for acetylcholinesterase and butyrylcholinesterase inhibitors Biochemistry 32 1993 12074 12084
3. P. Taylor, and Z. Radić The cholinesterases: from genes to proteins Annu. Rev. Pharmacol. Toxicol. 34 1994 281 320
4. Z. Kovarik, Z. Radić, B. Grgas, M. Škrinjarić- ŠpoljarReiner, E. Reiner, and V. Simeon-Rudolf Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline Biochim. Biophys. Acta 1433 1999 261 271
5. V. Simeon-Rudolf, Z. Kovarik, Z. Radić, and E. Reiner Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4′-bipyridine and by a coumarin derivative Chem. Biol. Interact. 119-120 1999 119 128
6. A. Ordentlich, D. Barak, C. Kronman, Y. Flashner, M. Leitner, Y. Segall, N. Ariel, S. Cohen, B. Velan, and A. Shafferman Dissection of the human acetylcholinesterase active center determinants of substrate specificity-identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket J. Biol. Chem. 268 1993 17083 17095
7. Y. Bourne, P. Taylor, and P. Marchot Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex Cell 83 1995 503 512
8. Y. Nicolet, O. Lockridge, P. Masson, J.C. Fontecellia-Camps, and F. Nachon Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products J. Biol. Chem. 278 2003 41141 41147
9. N.A. Hosea, H.A. Berman, and P. Taylor Specificity and orientation of trigonal carboxylesters and tetrahedral phosphonylesters in cholinesterase Biochemistry 34 1995 11528 11536
10. L. Wong, Z. Radić, R.J.M. Brüggemann, N. Hosea, H.A. Berman, and P. Taylor Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis Biochemistry 39 2000 5750 5757
11. Z. Kovarik, Z. Radić, H.A. Berman, V. Simeon-Rudolf, E. Reiner, and P. Taylor Acetylcholinesterase active centre and gorge conformations analyzed by combinatorial mutations and enantiomeric phosphonates Biochem. J. 2003 33 40
12. Z. Kovarik, Z. Radić, H.A. Berman, V. Simeon-Rudolf, E. Reiner, and P. Taylor Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates Biochemistry 43 2004 3222 3229
13. M. Čalić, A. Lucić Vrdoljak, B. Radić, D. Jelić, D. Jun, K. Kuča, and Z. Kovarik In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity Toxicology 219 2006 85 96
14. P. Marchot, R.B.G. Ravelli, M.L. Raves, Y. Bourne, D.C. Vellom, J. Kanter, S. Camp, J.L. Sussman, and P. Taylor Soluble monomeric acetylcholinesterase from mouse-expression, purification, and crystallization in complex with fasciculin Protein Sci. 5 1996 672 679
15. Z. Kovarik, Z. Radić, and P. Taylor Site-directed mutagenesis of acetylcholinesterase-a tool for studying structure/function relationship Period. Biol. 106 2004 289 294
16. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Featherstone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88 95
17. E. Reiner, M. Škrinjarić-ŠpoljarSimeon-Rudolf, and V. Simeon-Rudolf Binding site on acetylcholinesterase and butyrylcholinesterase for pyridinium and imidazolium oximes, and other reversible ligands Period. biol. 98 1996 325 329
18. Y.-P. Pang, T.M. Kollmeyer, F. Hong, J.-C. Lee, P.I. Hammond, S.P. Haugabouk, and S. Brimijoin Rational design of alkylene-linked bis-pyridiniumaldoximes as improved acetylcholinesterase reactivators Chem. Biol. 10 2003 491 502
19. M. Škrinjarić ŠpoljarSimeon, and V. Simeon Reactions of usual and atypical human serum cholinesterase phenotypes with progressive and reversible inhibitors J. Enzyme Inhib. 7 1993 169 174
20. M. Škrinjarić ŠpoljarSimeon, V. Simeon, E. Reiner, and B. Krauthacker Bispyridinium compounds: inhibition of human erythrocyte acetylcholinesterase and protection of the enzyme against phosphorylation Acta Pharm. Jugosl. 38 1988 101 109
21. E. Reiner, B. Krauthacker, V. Simeon, and M. Škrinjarić- Špoljar Mechanism of inhibition in vitro of mammalian acetylcholinesterase and cholinesterase in solutions of O,O-dimethyl 2,2,2-trichloro-1-hydroxyethyl phosphonate (trichlorophon) Biochem. Pharmacol. 24 1974 717 722
22. M. Škrinjarić-ŠpoljarSimeon, V. Simeon, and E. Reiner Spontaneous reactivation and aging of dimethylphosphorylated acetylcholinesterase and cholinesterase Biochem. Biophys. Acta 315 1973 363 369
23. F. Worek, C. Diepold, and P. Eyer Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics Arch. Toxicol. 73 1999 7 14
24. V. Simeon-Rudolf, E. Reiner, M. Škrinjarić- ŠpoljarRadić, B. Radić, A. Lucić, I. Primožič, and S. Tomić Quinuclidinium-imidazolium compounds: synthesis, mode of interaction with acetylcholinesterase and effect upon soman intoxicated mice Arch. Toxicol. 72 1998 289 295